GB Meka
Stocks to watch

AKBA

Compare

AKEBIA THERAPEUTICS INC · Healthcare

$0.90
▲ 2.0%Close 2026-09-30

Live intraday price

Compare with our price levels

T21.00
T10.96
E10.82
E30.67
SL0.62

Close 2026-09-30: $0.90 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting• Neutral

Not in the buy zone yet — needs to drop 9.4% · 1 whale recently bought

1 month
▼ 1.7%
3 months
▼ 25.3%
1 year
▼ 66.7%
Analyst target
$3.92 +333.5%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$0.82 -9.4%
E2$0.74 -17.7%
E3$0.67 -25.9%
Targets
T1$0.96 6.6%
T2$1.00 11.1%
T3$1.05 16.1%
Stop-loss
SL$0.62 -31.4%
Whale cost ~$1.97 117.7%

Risk : reward 1 : 2.1Moves ~$0.05 a day

⚖️ Positives and risks

✓ Positives (4)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 1 ราย
  • ●MACD เพิ่งตัดขึ้น (โมเมนตัมเริ่มกลับเป็นบวก)
  • ●ราคาเป้าหมายนักวิเคราะห์เฉลี่ย 3.92 (upside +334%, 6 ราย)
  • ●นักวิเคราะห์ส่วนใหญ่แนะนำ Strong Buy
! Risks (5)
  • ●แนวโน้มระยะยาวเป็นขาลง (ใต้ MA200 และ MA200 ชี้ลง)
  • ●อ่อนแอกว่าตลาด (S&P 500) -54% ใน 6 เดือน
  • ●รายได้หดตัว -21% เทียบปีก่อน
  • ●บริษัทยังขาดทุน (อัตรากำไรสุทธิติดลบ)
  • ●หนี้สูง D/E 796%

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-08-05In line -3%

Actual EPS -$0.03 · est. -$0.02 · After close

▼ 26.0%

Day 1

+3.0%

Next 20 days

2026-05-07Miss -7%

Actual EPS -$0.03 · est. -$0.03 · Before open

▼ 20.3%

Day 1

-20.8%

Next 20 days

2026-02-26Beat +17%

Actual EPS -$0.05 · est. -$0.06 · Before open

▲ 9.1%

Day 1

+5.3%

Next 20 days

2025-05-08Beat +162%

Actual EPS $0.02 · est. -$0.04 · Before open

▲ 6.5%

Day 1

+51.5%

Next 20 days

2025-03-13Miss -33%

Actual EPS -$0.10 · est. -$0.07 · Before open

▼ 12.4%

Day 1

-8.3%

Next 20 days

2024-11-07Miss -100%

Actual EPS -$0.10 · est. -$0.05 · Before open

▼ 6.7%

Day 1

+9.9%

Next 20 days

Listen to the earnings call or read the full report on AKBA's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$245M
Next earnings2026-11-09
P/E (price to earnings)-
Forward P/E (on expected earnings)-2.5
Revenue growth (YoY)-21.4%
Earnings growth (YoY)-
Net profit margin-13.5%
ROE-109.4%
Debt to equity (D/E)796%
Dividend yield-
Analyst targets (high / low)$6.00 / $1.00
Number of analysts6
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Downtrend ↘ · Downtrend ↘
RSI44
MA50 / MA200$1.00 / $1.24
Distance from MA200-27.1%
MACDJust crossed up
1-year high / low$3.20 / $0.81
vs. S&P 500 (6 months)-53.7%
Volume vs. average0.29×